Hbw Advisory Services LLC Gilead Sciences, Inc. Transaction History
Hbw Advisory Services LLC
- $726 Million
- Q2 2025
A detailed history of Hbw Advisory Services LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Hbw Advisory Services LLC holds 3,008 shares of GILD stock, worth $340,625. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,008
Previous 3,365
10.61%
Holding current value
$340,625
Previous $377,000
11.67%
% of portfolio
0.05%
Previous 0.06%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
2,292Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13.3 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.74 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.18 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.06 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $142B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...